Amman: Jordan’s drug industry sector occupies a “prominent and pioneering” position in the region, and its pharmaceutical products enter markets of 85 countries across the world, according to the Representative of the Curative Industries and Medical Supplies Sector at Jordan Chamber of Industry (JCI, Fadi Atrash.
In the past decade, he said the sector made “distinguished” results that made it a milestone in the national economy, especially the pharmaceutical industries, which formed a “true” success story worldwide.
In a statement “Petra” on Saturday, he said the volume of the sector’s existing production amounts to about JD1.62 billion annually, and its productivity constitutes approximately 10% of the total production of the Kingdom’s entire industrial sector.
Meanwhile, he noted average growth rate of the sector’s production during the past decade reached 8.8% annually.
Jordan’s pharmaceutical industries and medical supplies account for 3% of the gross domestic product, for their added value production operations, amounting to 51% of the sector’s total production, or about JD828 million, which constitutes 12% of the total added value of Jordan’s industrial sector, he said.
Atrash, who is also Executive Director and board member of Amman Pharmaceutical Industries (API) , said the sector has 151 establishments, with a registered capital of about JD341 million, while the number of Jordanian factories outside the Kingdom is 15, located in Saudi Arabia, Algeria, Egypt, Morocco and Sudan.
A “key” trait of the sector is its reliance on Jordanian manpower at various administrative and technical levels, who constitute more than 98% of the total number of 10,000 workers, and 35% of whom are female, he noted.
Source: Jordan News Agency